IL-2 and beyond in cancer immunotherapy

JM Wrangle, A Patterson, CB Johnson… - Journal of Interferon & …, 2018 - liebertpub.com
The development of the T-and natural killer (NK) cell growth factor IL-2 has been a sentinel
force ushering in the era of immunotherapy in cancer. With the advent of clinical grade …
被引用次数：132 相关文章

IL-2 and Beyond in Cancer Immunotherapy

JM Wrangle, A Patterson… - … of interferon & …, 2018 - pubmed.ncbi.nlm.nih.gov
The development of the T-and natural killer (NK) cell growth factor IL-2 has been a sentinel
force ushering in the era of immunotherapy in cancer. With the advent of clinical grade …

[引用][C] IL-2 and Beyond in Cancer Immunotherapy

JM Wrangle, A Patterson, CB Johnson… - Journal of Interferon & …, 2018 - cir.nii.ac.jp
IL-2 and Beyond in Cancer Immunotherapy | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …

IL-2 and Beyond in Cancer Immunotherapy

JM Wrangle, A Patterson, CB Johnson… - Journal of Interferon …, 2018 - search.proquest.com
The development of the T-and natural killer (NK) cell growth factor IL-2 has been a sentinel
force ushering in the era of immunotherapy in cancer. With the advent of clinical grade …

IL-2 and Beyond in Cancer Immunotherapy.

JM Wrangle, A Patterson, CB Johnson… - Journal of Interferon & …, 2018 - europepmc.org
The development of the T-and natural killer (NK) cell growth factor IL-2 has been a sentinel
force ushering in the era of immunotherapy in cancer. With the advent of clinical grade …
[HTML] nih.gov

[HTML][HTML] IL-2 and Beyond in Cancer Immunotherapy

JM Wrangle, A Patterson, CB Johnson… - Journal of Interferon & …, 2018 - ncbi.nlm.nih.gov
The development of the T-and natural killer (NK) cell growth factor IL-2 has been a sentinel
force ushering in the era of immunotherapy in cancer. With the advent of clinical grade …

IL-2 and beyond in Cancer Immunotherapy

JM Wrangle, A Patterson… - … of Interferon and …, 2018 - ohiostate.elsevierpure.com
The development of the T-and natural killer (NK) cell growth factor IL-2 has been a sentinel
force ushering in the era of immunotherapy in cancer. With the advent of clinical grade …